Rivotril 0,5 mg clonazepam tablets

Rivotril is a well-known pharmaceutical brand containing the active ingredient Clonazepam, commonly used to treat seizure disorders and panic attacks. The brand was originally developed and launched by the Swiss multinational healthcare company Hoffmann-La Roche (Roche).

While Roche maintains the original brand rights, the commercialization and distribution in many markets, including Spain, have been transitioned to Cheplapharm Arzneimittel GmbH. Manufacturing for these markets typically takes place in specialized pharmaceutical facilities across Europe, with Italy being a major manufacturing hub for these specific tablets. The brand identity remains synonymous with Swiss pharmaceutical innovation, though its current global footprint involves complex multinational licensing and production agreements.